D2B3

📍 New Haven, United States👥 3 employees💰 Last funded Jan 2026
Biotechnology Research🌐 d2b3.bio
Website LinkedIn
D2B3 is a pre-clinical biotechnology company dedicated to advancing drug delivery solutions to the brain and central nervous system. Its proprietary technology allows to transiently and specifically open the blood brain barrier for therapeutic targeting of CNS diseases with high efficacy. Our approach is plug-and-play and works with most drugs and therapeutic classes.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in D2B3?
D2B3 has 1 investors on record on gritt.io.
When did D2B3 last raise funding?
The most recent investment in D2B3 recorded on gritt.io was in January 2026.
What industry is D2B3 in?
D2B3 operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is D2B3 based?
D2B3 is headquartered in New Haven, United States.